Antihypertensive Drugs Market to

Antihypertensive drugs market accounted for $22,557 million in 2018, is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026

PORTLAND, OREGON, UNITED STATES, August 17, 2022 /EINPresswire.com/ -- Increase in geriatric population worldwide, rise in healthcare expenditure worldwide, and surge in prevalence of hypertension across the globe have augmented the growth of the global antihypertensive drugs market. Whereas, patent expirations of blockbuster drugs impede the market growth. On the other hand, high growth potential in developing economies is projected to provide lucrative opportunities in the near future.

The global antihypertensive drugs market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/436

Rise in the geriatric population, surge in healthcare expenditure, and rise in prevalence of hypertension across the globe drive the growth of the global antihypertensive drugs market. However, patent expirations of blockbuster drugs hamper the market growth. On the contrary, high growth potential in developing countries is expected to create lucrative opportunities in the near future.

The demand for antihypertensive drugs is on a rise, owing to surge in incidence of hypertension. Furthermore, rise in awareness related to treatment of hypertension across the globe is another factor that fuels the growth of the market.

Hypertension is a long-term medical condition, which is marked by the rise in blood pressure. Blood pressure is considered higher than normal when the systolic blood pressure is more than 140mm Hg or the diastolic blood pressure is more than 90 mm Hg. Moreover, this medical condition is accompanied with other complications such as dementia, heart failure, and kidney diseases. Therefore, this condition requires an early diagnosis and treatment. The drugs employed in the treatment of this condition are termed as antihypertensive. Different type of the antihypertensive drugs available in the market include calcium channel blockers and vasodilators.

Based on distribution channel, the market is categorized into retail pharmacy, hospital pharmacy, and e-commerce. The e-commerce websites and online drug stores segment is expected to register the fastest CAGR of 4.2% through 2026. On the other hand, the hospital pharmacy segment accounted for the highest share in 2018, contributing to more than half of the global antihypertensive drugs market.

North America dominated the market

The global antihypertensive drugs market across North America held the largest share in 2018, accounting for more than one-third of the market, owing to the availability of the antihypertensive drugs and rise in prevalence of hypertension due to surge in geriatric population in the region. However, the market across the Asia-Pacific region is anticipated to portray the fastest CAGR of 4.2% during the forecast period, owing to surge in awareness related to use of antihypertensive drugs and the presence of active key players in the region.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/436

Major market players

Boehringer Ingelheim GmbH
Johnson and Johnson
Merck KGaA
Pfizer, Inc.
Bayer AG
AstraZeneca plc
Takeda Pharmaceutical Co., Ltd.
Sanofi S.A.
Daiichi Sankyo Company
Novartis International AG

We also Offers Regional and Country Reports-

Japan Antihypertensive Drugs Market
South Korea Antihypertensive Drugs Market
Singapore Antihypertensive Drugs Market
China Antihypertensive Drugs Market
Indonesia Antihypertensive Drugs Market
Australia Antihypertensive Drugs Market
Taiwan Antihypertensive Drugs Market

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn